Literature DB >> 7427695

Immunoglobulin-bearing polymorphonuclear leucocytes in primary syphilis.

J D Bos, F Hamerlinck, R H Cormane.   

Abstract

Non-specific defence mechanisms are thought to be ineffective in eliminating Treponema pallidum after infection in the early stages, but studies aimed at the elucidation of this phenomenon are few. In this study, the number of IgG-bearing polymorphonuclear leucocytes in patients with primary syphilis was increased; this is most probably a normal phenomenon of infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7427695      PMCID: PMC1045780          DOI: 10.1136/sti.56.4.218

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  6 in total

1.  Isolation and removal of lymphocytes from bone marrow of rats and guinea-pigs.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

2.  T lymphoid cells in primary syphilis. Quantitative studies.

Authors:  J D Bos; F Hamerlinck; R H Cormane
Journal:  Br J Vener Dis       Date:  1980-04

3.  Immunoglobulin-bearing lymphoid cells in primary syphilis. Quantitative and elution studies.

Authors:  J D Bos; F Hamerlinck; R H Cormane
Journal:  Br J Vener Dis       Date:  1980-04

4.  Immunoglobulin and complement bearing polymorphonuclear leukocytes in allergic contact dermatitis and psoriasis vulgaris.

Authors:  J Hunyadi; F Hamerlinck; R H Cormane
Journal:  Br J Dermatol       Date:  1976-04       Impact factor: 9.302

5.  Treponema pallidum in early syphilitic lesions in humans during high-dosage penicillin therapy. An electron microscopical study.

Authors:  J Wecke; J Bartunek; G Stüttgen
Journal:  Arch Dermatol Res       Date:  1976-11-26       Impact factor: 3.017

6.  Nitroblue tetrazolium test in experimental syphilis.

Authors:  V Wicher; S Blakowski; K Wicher
Journal:  Br J Vener Dis       Date:  1977-10
  6 in total
  1 in total

Review 1.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.